The evaluation of the functional status and selected laboratory tests also represents a major part of the comprehensive assessment of stroke patients; functional status (for instance, independence in activities of daily living, mobility and balance) is commonly evaluated using different scales while parameters such as C-reactive protein (CRP), fibrinogen and D-dimer have been identified as prognostic biomarkers [12,13]. This evidence concerns the gene CRP and stroke disorder.